vanadium pentoxide has been researched along with Lung Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| MacGregor, JA; White, DJ; Williams, AL | 1 |
| MacGregor, JA; Starr, TB | 1 |
| Andersen, ME; Black, MB; Dodd, DE; Gollapudi, BB; MacGregor, JA; McMullen, PD; Pendse, S | 1 |
| Gollapudi, B; Haber, L; MacGregor, JA; Manjanatha, MG; Moore, MM; Rajendran, N; Shelton, SD | 1 |
| Banda, M; Gollapudi, BB; Haber, LT; MacGregor, JA; McKim, KL; Parsons, BL | 1 |
| Assem, FL; Levy, LS | 1 |
| Bauer, AK; Rondini, EA; Walters, DM | 1 |
| Ehman, KD; Macgregor, JA; Nikiforov, AI; Starr, TB | 1 |
| Anna, C; Devereux, TR; Holliday, W; Ress, N; Roycroft, J; Sills, RC | 1 |
| Bucher, JR; Chou, BJ; Dill, JA; Hailey, JR; Haseman, JK; Miller, RA; Renne, RA; Ress, NB; Roycroft, JH | 1 |
2 review(s) available for vanadium pentoxide and Lung Neoplasms
| Article | Year |
|---|---|
The limitations of using the NTP chronic bioassay on vanadium pentoxide in risk assessments.
Topics: Animals; Dose-Response Relationship, Drug; Humans; Inflammation; Inhalation Exposure; Lung; Lung Neoplasms; Risk Assessment; Toxicity Tests, Chronic; Vanadium Compounds | 2020 |
A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research.
Topics: Animals; Carcinogens; Environmental Exposure; Forecasting; Lung; Lung Neoplasms; Mice; Mutagens; Research; Vanadium Compounds | 2009 |
9 other study(ies) available for vanadium pentoxide and Lung Neoplasms
| Article | Year |
|---|---|
Vanadium pentoxide: risk assessment implications of a treatment- but not dose-related tumorigenic response in B6C3F1 mice.
Topics: Animals; Biological Assay; Carcinogenesis; Carcinogens; Female; Incidence; Inhalation Exposure; Lung; Lung Neoplasms; Male; Mice; Rats; Risk Assessment; United States; Vanadium Compounds | 2014 |
Using gene expression profiling to evaluate cellular responses in mouse lungs exposed to V2O5 and a group of other mouse lung tumorigens and non-tumorigens.
Topics: Animals; Apoptosis; Carcinogens; Cell Cycle; DNA Damage; Female; Gene Expression Profiling; Lung; Lung Neoplasms; Mice; Mice, Inbred Strains; Microarray Analysis; Oxidative Stress; Transcriptome; Vanadium Compounds | 2015 |
Evaluation of cII mutations in lung of male Big Blue mice exposed by inhalation to vanadium pentoxide for up to 8 weeks.
Topics: Administration, Inhalation; Animals; DNA Mutational Analysis; Dose-Response Relationship, Drug; Lung; Lung Neoplasms; Male; Mice, Transgenic; Mutagenicity Tests; Mutation; Organ Size; Time Factors; Transcription Factors; Vanadium Compounds; Viral Proteins | 2015 |
Quantification of Kras mutant fraction in the lung DNA of mice exposed to aerosolized particulate vanadium pentoxide by inhalation.
Topics: Administration, Inhalation; Aerosols; Animals; Carcinogenesis; Codon; DNA Mutational Analysis; Dose-Response Relationship, Drug; Lung; Lung Neoplasms; Male; Mice, Transgenic; Mutagenicity Tests; Mutation; Particulate Matter; Polymerase Chain Reaction; Proto-Oncogene Proteins p21(ras); Time Factors; Vanadium Compounds | 2015 |
Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner.
Topics: Air Pollutants; Animals; Carcinogens; Chemokines; Disease Models, Animal; Genetic Predisposition to Disease; Inhalation Exposure; Lung Injury; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C57BL; Species Specificity; Transcription Factors; Vanadium Compounds | 2010 |
Vanadium pentoxide: use of relevant historical control data shows no evidence for a carcinogenic response in F344/N rats.
Topics: Adenocarcinoma; Adenoma; Administration, Inhalation; Animals; Carcinogenicity Tests; Carcinogens; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Male; Mice; Rats; Rats, Inbred F344; Species Specificity; Time Factors; United States; Vanadium Compounds | 2012 |
Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Carcinogens; Chromosome Mapping; Enzyme Activation; Female; Genes, ras; Loss of Heterozygosity; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Mitogen-Activated Protein Kinases; Mutagenesis; Phosphorylation; Vanadium Compounds | 2002 |
NTP toxicology and carcinogensis studies of vanadium pentoxide (CAS No. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation).
Topics: Animals; Body Burden; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Inhalation Exposure; Lung; Lung Neoplasms; Male; Mice; Pulmonary Alveoli; Rats; Rats, Inbred F344; Vanadium Compounds | 2002 |
Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice.
Topics: Adenoma; Administration, Inhalation; Animals; Body Weight; Carcinogenicity Tests; Carcinogens; Carcinoma; Female; Longevity; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Rats; Rats, Inbred F344; Respiratory System; Vanadium Compounds | 2003 |